NGM Biopharmaceuticals Inc buy Citigroup Inc.
Start price
03.05.23
/
50%
€3.48
Target price
03.05.24
€5.43
Performance (%)
-59.48%
End price
04.05.24
-
Summary
This prediction is currently being closed. Massive losses of -59.48% have been the result for the BUY prediction by Citigroup_Inc_. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
NGM Biopharmaceuticals Inc | - | - | - |
iShares Core DAX® | -0.654% | 1.989% | 14.984% |
iShares Nasdaq 100 | 0.903% | 5.664% | 36.140% |
iShares Nikkei 225® | -0.740% | -1.363% | 10.792% |
iShares S&P 500 | -0.013% | 3.020% | 28.126% |
Comments by Citigroup_Inc_ for this prediction
In the thread NGM Biopharmaceuticals Inc diskutieren
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for NGM provided by MarketBeat
In the thread Trading NGM Biopharmaceuticals Inc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten